Essential thrombocythemia and non-Hodgkin lymphoma: A case report

F. Radaelli, M. Colombi, L. Cro, R. Calori, L. Baldini

Research output: Contribution to journalArticle


A 67-year-old man with essential thrombocythemia treated with alkylating agents developed a small lymphocytic lymphoma after 102 months of therapy. Given the rareness of such an association, this case is reported because the cytoreductive treatment may have contributed to the onset of the lymphoma.

Original languageEnglish
Pages (from-to)177-179
Number of pages3
JournalCurrent Therapeutic Research
Issue number2
Publication statusPublished - 1993


ASJC Scopus subject areas

  • Medicine(all)

Cite this